Genmab — April 2017
-
Jeg ved ikke hvad det betyder. Det er jo længe siden, at genmab annoncerede at studiet var fuldt rekrutteret. Jeg troede, at de derved havde nået de 700 pts. Men de fleste lokationer rekrutterer stadig på livet løs. Det undrer mig også at de udvider med 30 lokationer uden at samlet antal pts øges.
-
Gætter på, at completed locations allerede har haft PFS events for alle deltagende patienter - ellers skulle der gå ca 41 måneder inden PFS assessment, og det kan jeg ikke engang få til at passe med start i dec 2014 og "Estimated Primary Completion Date" nov. 2017 - go figure...
-
https://www.dovepress.com/new-developments-in-the-treatment-of-multiple-myeloma---clinical-utili-peer-reviewed-article-BTT "New developments in the treatment of multiple myeloma – clinical utility of daratumumab"
-
Hvad tror i at salgstallene ender på for marts? tror i de ender på omkring
70 mio dollars? -
Sidste måned var jo berørt af at februar er en kort måned og marts er jo en lang
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind